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Abstract
Background: Bronchopulmonary dysplasia, a complex chronic lung disease in premature children
in which oxidative stress and surfactant deficiency play a crucial role, is characterized by arrested
alveolar and vascular development of the immature lung. The spatial and temporal patterns of
expression of surfactant proteins are not yet fully established in newborn infants and animal models
suffering from BPD.
Methods: We studied the mRNA expression of surfactant proteins (SP) A, -B, -C and -D and Clara
cell secretory protein (CC10) with RT-PCR and in situ hybridization and protein expression of
CC10, SP-A and -D with immunohistochemistry in the lungs of a preterm rat model, in which
experimental BPD was induced by prolonged oxidative stress.
Results: Gene expression of all surfactant proteins (SP-A, -B, -C and -D) was high at birth and
initially declined during neonatal development, but SP-A, -B, and -D mRNA levels increased during
exposure to hyperoxia compared to room-air controls. Peak levels were observed in adult lungs
for SP-A, SP-C and CC10. Except for SP-A, the cellular distribution of SP-B, -C, -D and CC10,
studied with in situ hybridization and/or immunohistochemistry, did not change in room air nor in
hyperoxia. Exposure to normoxia was associated with high levels of SP-A mRNA and protein in
alveolar type 2 cells and low levels in bronchial Clara cells, whereas hyperoxia induced high levels
of SP-A expression in bronchial Clara cells.
Conclusion: The increased expression of SP-A mRNA under hyperoxia can be attributed, at least
in part, to an induction of mRNA and protein expression in bronchial Clara cells. The expanded
role of Clara cells in the defence against hyperoxic injury suggests that they support alveolar type
2 cell function and may play an important role in the supply of surfactant proteins to the lower
airways.
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Background
Bronchopulmonary dysplasia (BPD) is a chronic lung dis-
ease that continues to be a leading cause of mortality and
morbidity in preterm infants with respiratory distress syn-
drome (RDS) despite improved ventilation support and
surfactant therapy. BPD is defined clinically by the need
for extra oxygen at 36 weeks of gestation, and mainly
affects infants born at less than 30 weeks of gestation with
a birth weight less than 1,200 g [1,2]. This multifactorial
chronic lung disease is characterized by decreased alveo-
larization and abnormal vascularization and associated
with surfactant deficiency, oxidative stress, barotrauma,
inflammation, alveolar fibrin deposition, nutrition, and
genetic background [1,3]. The (in)balance between initi-
ating factors and host characteristics probably determines
whether BPD will occur in a preterm infant. In animal
models, including premature baboons, neonatal mice and
rats, exposure to hyperoxia results in chronic lung disease
which closely resembles BPD in preterm infants [4-9].
Surfactant deficiency and immaturity are pivotal risk fac-
tors for developing RDS and, subsequently, BPD in pre-
term infants [10]. Surfactant therapy dramatically
improves the pathophysiology of BPD in preterm infants
[11] and attenuates injury, induced by oxidative stress in
rodents [12-15]. Various studies have reported the expres-
sion of surfactant proteins and CC10 during normal
development and under pathological conditions [16-22],
but the temporal and spatial distribution patterns of the
mRNAs of SP-A, -B, -C and -D and CC10 during normal
postnatal lung development and in prolonged hyperoxia
in the rat are not fully established. In our laboratory we
investigate the pathophysiology of bronchopulmonary
dysplasia (BPD) to develop new treatment modalities for
this chronic lung disease, using the hyperoxia-exposed
preterm rat as a model for experimental BPD [9,23]. In
this study we quantified mRNA expression of the sur-
factant protein genes and CC10 during normal rat lung
development and prolonged exposure to hyperoxia with
RT-PCR and followed the temporal and spatial distribu-
tion with in situ hybridization. We found that all sur-
factant proteins show a high level of expression at birth
and decline during neonatal development in normoxia,
whereas the expression of SP-A, -B and -D, but not SP-C,
increases in hyperoxia. CC10 expression was not different
under both experimental conditions. Peak levels were
observed in adult lungs for SP-A, SP-C and CC10. The
increased expression of SP-A mRNA during exposure to
hyperoxia could be attributed to an induction of SP-A
expression in bronchial epithelial Clara cells.
Methods
Animals
Timed-pregnant and 6 months old male Wistar rats were
kept in a 12 h dark-light cycle and fed a standard chow
diet (Special Diet Services, Witham, Essex, United King-
dom) ad libitum. Breeding pairs were allowed access for
one hour at the day female Wistar rats showed very spe-
cific sexual behaviour: lordosis, hopping and air-flapping.
After a gestation of approximately 211/2 days pregnant
Wistar rats were killed by decapitation (spontaneous birth
occurs 22 days after conception) and pups delivered by
hysterectomy through a median abdominal incision to
ensure that the delay in birth between the first and the last
pup is only 5 minutes. Immediately after birth, pups were
dried and stimulated. Pups of 2–3 litters, with a maxi-
mum of 12 pups, were pooled and exposed to 100% oxy-
gen in a transparent 50×50×70 cm Plexiglas chamber for
10 days. In this way influences of the birth process within
and between litters can be avoided and exposure to hyper-
oxia can be started within 30 minutes after birth. Pups
were fed by lactating fosters. To avoid oxygen toxicity of
the foster mothers, two groups of 5 pups exposed to room
air were included and used to generate data on room air-
exposed controls. Foster mothers were rotated daily
between the 3 cages. The research protocol was approved
by the Institutional Animal Care and Use Committee of
the Leiden University Medical Center.
Tissue preparation
Pups were anesthesized with an intraperitoneal injection
of ketamine (50 mg/kg bodyweight, Ketanest-S™ Parke-
Davis/Pfizer, New York, NY, USA) and xylazine (50 mg/kg
bodyweight, Rompun™, Bayer AG, Leverkusen, Germany).
To avoid post-mortem fibrin deposition in the lungs,
heparin (100 units, Leo Pharma, Breda, the Netherlands)
was injected intraperitoneally. After 5 min, pups were
exsanguinated by transection of the abdominal blood ves-
Table 1: Sequences of oligonucleotides used as forward and reverse primers for real-time RT-PCR
Gene product Forward primer Reverse primer
SP-A 5'-TACCAGAGCAGGAGGCAACA-3' 5'-CAATACTTGCAATGGCCTCGTT-3'
SP-B 5'-CCATCCCTCTGCCCTTCTG-3' 5'-CACCCTTGGGAATCACAGCTT-3'
SP-C 5'-TCCCAGGAGCCAGTTTCG-3' 5'-CACGATGAGAAGGCGTTTGA-3'
SP-D 5'-AAATCTTCAGGGCGGCAAA-3' 5'-GGCCTGCCTGCACATCTC-3'
CC10 5'-TTACAACATCAGCCCACATCTACA-3' 5'-TGTGATGCCGATCTTCATGGT-3'
β-actin 5'-TTCAACACCCCAGCCATGT-3' 5'-AGTGGTACGACCAGAGGCATACA-3'BMC Pulmonary Medicine 2006, 6:8 http://www.biomedcentral.com/1471-2466/6/8
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sels. The thoracic cavity was opened and the lungs were
removed, snap-frozen in liquid nitrogen and stored at -
80°C until use for real-time RT-PCR. For histology studies
and in situ hybridization, the trachea was cannulated
(Bioflow 0.6 mm i.v. catheter, Vygon, Veenendaal, the
Netherlands) and the lungs were fixed in situ via the tra-
chea cannula with buffered formaldehyde (4% parafor-
maldehyde in phosphate buffered saline, pH 7.4) at 25
cm H2O pressure for 3 min. Lungs were removed, fixed
additionally in formaldehyde for 24 h at 4°C, and embed-
ded in paraffin after dehydration in a graded alcohol
series and xylene.
Real-time RT-PCR
Total RNA was isolated from lung tissue homogenates
using guanidium-phenol extraction (RNAzol™, Campro
Scientific, Veenendaal, the Netherlands). Briefly, after tis-
sue homogenization in RNAzol B, RNA was isolated using
phenol-chloroform extraction and isopropanol precipita-
tion. The RNA sample was dissolved in RNase-free water
and quantified spectrophotometrically. The integrity of
the RNA was studied by gel electrophoresis on a 1% agar-
ose gel, containing ethidium bromide. Samples showing
degradation of ribosomal RNA by visual inspection under
UV-light were discarded. First strand cDNA synthesis was
performed with the SuperScript™ Choice System (Life
mRNA expression of Clara cell secretory protein, deter- mined with in situ hybridization on formaldehyde fixed paraf- fin sections of rat lungs during normal postnatal development  at birth (A), day 6 (C), day 10 (E) and 6 months (B) and after  exposure to hyperoxia on day 6 (D) and 10 (F) at a 200-fold  magnification Figure 2
mRNA expression of Clara cell secretory protein, deter-
mined with in situ hybridization on formaldehyde fixed paraf-
fin sections of rat lungs during normal postnatal development 
at birth (A), day 6 (C), day 10 (E) and 6 months (B) and after 
exposure to hyperoxia on day 6 (D) and 10 (F) at a 200-fold 
magnification. a = alveolus, br = bronchus, bv = blood vessel, 
s = saccule, tb = terminal bronchus.
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Relative mRNA expression, determined with RT-PCR, of  surfactant proteins A (A), -B (B), -C (C) and -D (D) and  Clara cell secretory protein CC10 (E) in oxygen-exposed  (black bars) and control pups (white bars) in neonatal lungs  on days 1, 3, 6, and 10 Figure 1
Relative mRNA expression, determined with RT-PCR, of 
surfactant proteins A (A), -B (B), -C (C) and -D (D) and 
Clara cell secretory protein CC10 (E) in oxygen-exposed 
(black bars) and control pups (white bars) in neonatal lungs 
on days 1, 3, 6, and 10. In panel F adult mRNA expression is 
depicted by black bars and neonatal expression in room air-
exposed controls on day 3 by white bars. Data are expressed 
as mean ± SEM of 9 (day 1) or 6 (days 3, 6 and 10, and 6 
months) rats. *: p < 0.05; **: p < 0.01, ***: p < 0.001 versus 
age-matched controls (panels A-E) or versus day 3 room air 
(panel F). ∆: p < 0.05, ∆∆: p < 0.01, ∆∆∆: p < 0.001 versus 
day 1.
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Technologies, Breda, the Netherlands) by mixing 2 µg
total RNA with 1 µg Oligo(dT)12–18 primer in a total vol-
ume of 10 µl. After heating the mixture at 70°C for 10
min, a solution containing 50 mM Tris-HCl (pH 8.3), 75
mM KCl, 3 mM MgCl2, 10 mM DTT, 0.5 mM dNTPs, 0.5
µl RNase inhibitor, and 200 U Superscript Reverse Tran-
scriptase was added, resulting in a total volume of 20 µl.
This mixture was incubated at 42°C for 1 h, total volume
was adjusted to 100 µl with RNase-free water, and stored
at -80°C until further use. For real-time quantitative PCR
1 µl first strand cDNA, diluted 1:10 in RNase-free water,
was used in a total volume of 25 µl, containing 12.5 µl 2
× SYBR Green PCR Master Mix (Applied Biosystems, Fos-
ter City, CA, USA) and 200 ng of each primer. Primers,
designed with the Primer Express™ software package
(Applied Biosystems, Foster City CA, USA), are listed in
Table 1. PCR reactions, consisting of 95°C for 10 min (1
cycle), 94°C for 15 sec and 60°C for 1 min (40 cycles),
were performed on an ABI Prism 7700 Sequence Detec-
tion System (Applied Biosystems, Foster City CA, USA).
Data were analyzed with the ABI Prism 7700 Sequence
Detection System version 1.9 software and quantified
using the comparative threshold cycle method with β-
actin as a housekeeping gene reference [24]. We studied at
least 6 animals per experimental group.
In situ hybridization
Paraffin sections (7 µm) from the left upper lobe were cut
and mounted onto SuperFrost plus coated slides (Menzel-
Gläzer, Braunschweig, Germany). The in situ hybridiza-
tion procedure was based on the method described by
mRNA expression of surfactant protein B, determined with  in situ hybridization on formaldehyde fixed paraffin sections  of rat lungs during normal postnatal development at birth  (A), day 6 (C), day 10 (E) and 6 months (B) and after expo- sure to hyperoxia on day 6 (D) and 10 (F) at a 200-fold mag- nification Figure 4
mRNA expression of surfactant protein B, determined with 
in situ hybridization on formaldehyde fixed paraffin sections 
of rat lungs during normal postnatal development at birth 
(A), day 6 (C), day 10 (E) and 6 months (B) and after expo-
sure to hyperoxia on day 6 (D) and 10 (F) at a 200-fold mag-
nification. a = alveolus, br = bronchus, bv = blood vessel, s = 
saccule, tb = terminal bronchus.
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mRNA expression of surfactant protein A, determined with  in situ hybridization on formaldehyde fixed paraffin sections  of rat lungs during normal postnatal development at birth  (A), day 3 (C), day 6 (E) day 10 (G) and 6 months (B) and  after exposure to hyperoxia on day 3 (D), 6 (F) and 10 (H) at  a 200-fold magnification Figure 3
mRNA expression of surfactant protein A, determined with 
in situ hybridization on formaldehyde fixed paraffin sections 
of rat lungs during normal postnatal development at birth 
(A), day 3 (C), day 6 (E) day 10 (G) and 6 months (B) and 
after exposure to hyperoxia on day 3 (D), 6 (F) and 10 (H) at 
a 200-fold magnification. a = alveolus, ad = alveolar duct, br = 
bronchus, bv = blood vessel, s = saccule, tb = terminal bron-
chus.
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Wilkinson [25]. Sections were deparaffined, digested with
proteinase K (Roche, Almere, The Netherlands), postfixed
in 4% paraformaldehyde, treated with 0.2 M HCl to block
endogenous alkaline phosphatase activity, acetylated with
acetic anhydride dissolved in triethanolamine and hybrid-
ized with digoxygenine-labeled probe in hybridization
buffer overnight at 55 °C. cRNA probe concentrations
were 20 ng/section for CC10, SP-B and SP-C, 30 ng/sec-
tion for SP-A, and 40 ng/section for SP-D. The hybridiza-
tion buffer contained 9/10 (volume) hybridization
mixture: 50% formamide, 2 × SSC, 1 × Denhardt's solu-
tion and 10% dextran sulphate and 1/10 (volume) probe
solution: 0.1–1 ng/µl cRNA probe and 1 µg/µl yeast RNA
in distilled water. After hybridization, high stringency
washing was performed in 50% formamide/2 × SSC at 55
°C. Sections were treated with RNase A, rinsed in 2 × SSC,
blocked with lamb serum (Invitrogen, Paisley, England)
and incubated with anti-digoxygenine-alkaline phos-
phatase conjugated Fab fragments (Roche, Almere, The
Netherlands) for 2 hours. Sections were washed exten-
sively with Tris-buffered saline (100 mM Tris, 150 mM
NaCl, pH 7.5) and incubated with NBT/BCIP solution
(Roche, Almere, The Netherlands), dissolved in 6% poly-
vinyl alcohol, overnight in the dark. The staining reaction
was terminated with TE-buffer (10 mM Tris/HCl, 1 mM
EDTA, pH 8.0). Subsequently, sections were counter-
stained with nuclear fast red, dehydrated with an ethanol
series, and mounted in Euparal. As a negative control
RNase pretreated sections were used prior to hybridiza-
tion, which did not give any staining at all. We studied a
minimum of four animals per time-point.
mRNA expression of surfactant protein D, determined with  in situ hybridization on formaldehyde fixed paraffin sections  of rat lungs during normal postnatal development at birth  (A), day 6 (C), 10 (E) and 14 (B) and after exposure to hyper- oxia on day 6 (D) and 10 (F) at a 200-fold magnification Figure 6
mRNA expression of surfactant protein D, determined with 
in situ hybridization on formaldehyde fixed paraffin sections 
of rat lungs during normal postnatal development at birth 
(A), day 6 (C), 10 (E) and 14 (B) and after exposure to hyper-
oxia on day 6 (D) and 10 (F) at a 200-fold magnification. a = 
alveolus, br = bronchus, bv = blood vessel, s = saccule, tb = 
terminal bronchus.
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mRNA expression of surfactant protein C, determined with  in situ hybridization on formaldehyde fixed paraffin sections  of rat lungs during normal postnatal development at birth  (A), day 6 (C), 10 (E) and 6 months (B) and after exposure to  hyperoxia on day 6 (D) and 10 (F) at a 200-fold magnification Figure 5
mRNA expression of surfactant protein C, determined with 
in situ hybridization on formaldehyde fixed paraffin sections 
of rat lungs during normal postnatal development at birth 
(A), day 6 (C), 10 (E) and 6 months (B) and after exposure to 
hyperoxia on day 6 (D) and 10 (F) at a 200-fold magnification. 
a = alveolus, br = bronchus, bv = blood vessel, s = saccule, tb 
= terminal bronchus.
AB
br
s
s
tb
bv
br
bv
a
C D
br br
br
a
a
tb
EF
br
a
bv
br
br
bv
aBMC Pulmonary Medicine 2006, 6:8 http://www.biomedcentral.com/1471-2466/6/8
Page 6 of 11
(page number not for citation purposes)
Digoxygenine-labeled anti-sense cRNA probes to rat SP-A,
SP-B, SP-C, SP-D and CC10 were made by in vitro tran-
scription using pBluescript (SP-A), pGEM 4Z (SP-D) and
pCR4-TOPO (SP-B, SP-C and CC10) as vectors, contain-
ing a 662 bp rat SP-A cDNA fragment [26], a 998 bp SP-B
fragment, a 521 bp SP-C fragment, a full length SP-D frag-
ment [27] and a 416 bp CC10 fragment. Primers used to
generate PCR fragments for SP-B, SP-C and CC10 from a
first strand cDNA rat lung (10 days after birth) sample (see
real-time RT-PCR section) were designed with primer3
software and are listed in Table 2. PCR reactions, consist-
ing of 95°C for 5 min (1 cycle), 95°C for 1 min, 60°C for
1 min and 72 °C for 1 min (40 cycles) and 72°C for 30
min were performed in the presence of Amplitaq gold
(Invitrogen, Paisley, England) on a Perkin Elmer Gene-
Amp PCR system 9600 (Perkin Elmer, Boston, MA, USA).
PCR fragments were subsequently cloned into pCR4-
TOPO vector exactly as described by the manufacturer
(Invitrogen, Breda, The Netherlands) and checked by
restriction fragment analysis and sequencing.
Immunohistochemistry
Paraffin sections (5 µm) from the left upper lobe were cut
and mounted onto SuperFrost plus coated slides (Menzel-
Gläzer, Braunschweig, Germany). After deparaffinization
sections were incubated with 0.3% H2O2 in methanol to
block endogenous peroxidase activity. After a graded alco-
hol series, sections were pretreated for antigen retrieval
prior to antibody incubation. For the detection of CC10
and SP-A sections were boiled in 0.01 M sodium citrate
(pH 6.0) for 10 min. For the detection of SP-D sections
were digested with proteinase K, 20 mg/ml in a buffer
containing 100 mM Tris/HCl, 50 mM EDTA, pH 8.0 for
30 minutes. Hereafter sections were incubated overnight
with rabbit anti-rat CC10 (C5828-03, United States Bio-
logical, Swampscott, MA), rabbit anti-rat SP-A and mouse
anti-rat SP-D (HM3022, Hycult Biotechnology, Uden, The
Netherlands) and stained with EnVision-HRP (Dako,
Glostrup, Denmark), using NovaRed (Vector, Burlin-
game, CA, USA) as chromogenic substrate. Sections were
counterstained briefly with hematoxylin. SP-B and SP-C
protein expression could not be evaluated due to a limited
supply of anti-rat SP-B and high background activity in
incubations with anti-rat SP-D.
Statistical analysis
Values are expressed as mean ± SEM. Differences between
groups were analyzed with the Student's t-test. P-values <
0.05 were considered statistically significant.
Results
RT-PCR
mRNA expression of SP-A, SP-B, SP-C, SP-D and CC10
was studied in lungs of hyperoxia-exposed pups on neo-
natal days 3, 6 and 10, and age-matched controls on days
1, 3, 6 and 10, and at 6 month of age with normal pulmo-
nary development (Figure 1). To exclude the effects of
birth on gene expression, mRNA expression on neonatal
day 3 in room air exposed controls was used as a reference
value. The collectins SP-A (panel A) and SP-D (panel D)
showed similar expression patterns during normal neona-
tal lung development and in hyperoxia. Highest expres-
sion in control lungs was observed at birth and decreased
gradually thereafter. SP-A decreased 2.1-fold (p = 0.0001)
and 1.5-fold (p = 0.0169) on days 6 and 10, respectively,
and SP-D decreased 1.9-fold (p < 0.0001) on day 10, com-
pared to expression at birth. During exposure to hyper-
oxia, SP-A and SP-D expression on day 3 decreased 1.9-
fold (p = 0.0038) and 1.25-fold (p = 0.0174), respectively,
compared to age-matched controls. Thereafter, expression
of SP-A and SP-D gradually increased in hyperoxia, result-
Immunohistochemical staining of Clara cell secretory protein  on formaldehyde fixed paraffin sections of rat lungs during  normal postnatal development at birth (A), day 6 (C), day 10  (E) and 6 months (B) and after exposure to hyperoxia on day  6 (D) and 10 (F) at a 200-fold magnification Figure 7
Immunohistochemical staining of Clara cell secretory protein 
on formaldehyde fixed paraffin sections of rat lungs during 
normal postnatal development at birth (A), day 6 (C), day 10 
(E) and 6 months (B) and after exposure to hyperoxia on day 
6 (D) and 10 (F) at a 200-fold magnification. a = alveolus, br = 
bronchus, bv = blood vessel, s = saccule, tb = terminal bron-
chus.
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ing in an 1.8-fold (p = 0.0066) and a 2.3-fold (p = 0.0001)
increase on day 10 for SP-A and SP-D, respectively, com-
pared to age-matched controls, indicating that the magni-
tude of the effect of hyperoxia on gene expression is
related with the duration of oxygen exposure.
The hydrophobic surfactant proteins SP-B (panel B) and
SP-C (panel C) showed a similar expression pattern dur-
ing normal neonatal development. Expression was high-
est at birth and decreased thereafter with a 2.0-fold (p <
0.0001) decrease for SP-B and an 1.4-fold decrease (p =
0.0104) for SP-C on day 10. In hyperoxia, SP-B showed an
1.4-fold (p = 0.0009) increase in expression on day 10,
compared to age-matched controls. Expression of SP-C
did not change in hyperoxia. Expression of CC10 mRNA
did not change during normal neonatal lung develop-
ment and in hyperoxia (panel E).
In adult lung mRNA expression of SP-A, SP-C, SP-D and
CC10 was increased 6.4-fold (p < 0.0001), 2.0-fold (p =
0.0007), 1.3-fold (p = 0.0446) and 2.4-fold (p < 0.0001),
respectively, compared with mRNA expression on day 3 in
room air (panel F).
In situ hybridization and immunohistochemistry
To investigate whether differential mRNA expression of
SP-A, -B, -C, -D and CC10 could be attributed to changes
in gene expression at the cellular level we studied the spa-
tial and temporal expression of these genes during normal
neonatal lung development until adulthood and in exper-
imental BPD at the mRNA level with in situ hybridization
(SP-A, -B, -C, -D and CC10) and at the protein level with
immunohistochemistry (SP-A, -D and CC10). Expression
was studied in the lung during the first two weeks after
birth, in which the transition from the saccular to the alve-
olar developmental stage takes place, in hyperoxia-
exposed pups on neonatal days 1, 3, 6 and 10, in age-
matched room-air exposed controls, including day 14,
and in adult rat lungs. As a positive control for Clara cells
we studied the expression of CC10 mRNA (Figure 2) and
protein (Figure 7) and used this as a reference for sur-
factant protein expression in bronchial epithelial Clara
cells. From birth (Figure 2, panel A) onward CC10 mRNA
was predominantly, but not exclusively, expressed at high
levels in the bronchial epithelium in non-ciliated cuboi-
dal cells, consistent with the morphological definition of
Clara cells [28], but also at a low level in alveolar type 2
cells. This pattern of mRNA expression did not change
during postnatal development on days 3, 6 (panel C) and
10 (panel E) until adulthood (panel B) and after exposure
to hyperoxia on days 3, 6 (panel D) and 10 (panel F). In
contrast to its mRNA CC10 protein (Figure 7) was absent
in alveolar type 2 cells and was exclusively expressed in
bronchial epithelial Clara cells from birth onward (panel
A). This pattern of protein expression did not change dur-
ing postnatal development on days 3, 6 (panel C) and 10
(panel E) until adulthood (panel B) and after exposure to
hyperoxia on days 3, 6 (panel D) and 10 (panel F).
SP-A mRNA was expressed from birth (Figure 3, panel A)
until day 10 (panel G) in alveolar type 2 cells and in the
epithelial lining of terminal bronchi and the alveolar
duct, but was absent in the epithelium of more upstream
localized bronchi. A relatively low level of SP-A expression
was observed in bronchial epithelial cells at two weeks
after birth and in adult lungs (panel B). Hyperoxia
resulted in an induction of SP-A expression in the bron-
chial epithelium in Clara cells from day 6 onward (panel
F), resulting in a high level of expression in alveolar type
2 cells and, in contrast to age-matched controls, in the epi-
Immunohistochemical staining of surfactant protein A on for- maldehyde fixed paraffin sections of rat lungs during normal  postnatal development on day 3 (A), day 6 (C) and day 10 (E)  and after exposure to hyperoxia on day 3 (B), 6 (D) and 10  (F) at a 200-fold magnification Figure 8
Immunohistochemical staining of surfactant protein A on for-
maldehyde fixed paraffin sections of rat lungs during normal 
postnatal development on day 3 (A), day 6 (C) and day 10 (E) 
and after exposure to hyperoxia on day 3 (B), 6 (D) and 10 
(F) at a 200-fold magnification. a = alveolus, br = bronchus, 
bv = blood vessel, s = saccule, tb = terminal bronchus.
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thelial lining of the bronchi (Clara cells) on day 10 (panel
H). SP-A protein expression at birth was low. Similar to its
mRNA SP-A protein (Figure 8) was expressed from day 3
(panel A) until day 10 (panel E) in alveolar type 2 cells
and in epithelial cells of the alveolar duct and terminal
bronchi. Hereafter SP-A protein was expressed in alveolar
type 2 cells and in bronchial epithelial Clara cells (not
shown). At day 3 SP-A expression was similar in hyper-
oxia-exposed lungs (panel B) and in age-matched controls
(panel A). From day 6 (panel D) onward hyperoxia also
resulted in an induction of SP-A expression in the bron-
chial epithelium in Clara cells, resulting in a high level of
expression in alveolar type 2 cells and, in contrast to age-
matched controls, in the epithelial lining of the bronchi
(Clara cells) on day 10 (panels D and F).
At birth a high level of expression of SP-B mRNA was
observed in alveolar type 2 cells and in the bronchial epi-
thelium in Clara cells (Figure 4, panel A). Hereafter, SP-B
expression did not change significantly during normal
neonatal development on days 6 (panel C) and 10 (panel
E) until adulthood (panel B) and after exposure to 100%
oxygen on days 6 (panel D) and 10 (panel F).
From birth onward SP-C mRNA (Figure 5, panel A) was
exclusively present in the alveolar epithelium, including
the alveolar duct and alveolar type 2 cells, but was absent
in the bronchial epithelium on days 6 (panel C) and 10
(panel E) until adulthood (panel B). The SP-C expression
pattern did not change during exposure to hyperoxia for 6
days (panel D) and 10 days (panel F).
Expression of SP-D mRNA was almost complementary to
that of the other collectin SP-A and CC10, showing a high
level of expression in bronchial Clara cells and a very low
level of expression in alveolar type 2 cells after birth (Fig-
ure 6, panel A) until day 14 (panel B). This pattern of
mRNA expression in the lung did not change after expo-
sure to 100% oxygen (day 10, panel F). In adult lungs SP-
D mRNA expression was below the detection level (not
shown). At birth SP-D protein expression was relatively
low and was observed in alveolar type 2 cells and in bron-
chial Clara cells, showing highest expression in alveolar
type 2 cells (Figure 9, panel A). Hereafter, SP-D protein
expression was similar as its mRNA expression, showing a
high level of expression in bronchial epithelial Clara cells
and to a lesser extent in alveolar type 2 cells. This pattern
did not change during normal post-natal development
until adulthood and after hyperoxia. However, hyperoxia
reduced the overall expression of SP-D, resulting in a very
low expression on day 10 in both alveolar type 2 cells and
in bronchial epithelial cells (panel F).
Discussion
Using a preterm rat model we quantified mRNA expres-
sion and investigated the temporal and spatial expression
of surfactant proteins (SP) A, B, C and D, and Clara cell
secretory protein (CC10) at the mRNA level and SP-A, -B
and CC10 at the protein level during normal neonatal
pulmonary development and in experimental BPD
induced by oxidative stress. mRNA levels of all surfactant
proteins were high at birth and increased after prolonged
exposure to hyperoxia, compared to age-matched con-
trols. Peak levels were observed in adult lungs for SP-A
and SP-C. Expression of CC10 mRNA did not change dur-
ing normal neonatal lung development and exposure to
hyperoxia, but peaked in adult lung. An upregulation of
surfactant protein expression at the mRNA level after pro-
longed hyperoxia in premature rat pups confirms the
results obtained for SP-A, -B, -C and/or -D in neonatal rab-
bits [18,20], neonatal rats [21], adult rabbits [19,29] and
Immunohistochemical staining of surfactant protein D on for- maldehyde fixed paraffin sections of rat lungs during normal  postnatal development at birth (A), day 6 (C), day 10 (E) and  6 months (B) and after exposure to hyperoxia on day 6 (D)  and 10 (F) at a 200-fold magnification Figure 9
Immunohistochemical staining of surfactant protein D on for-
maldehyde fixed paraffin sections of rat lungs during normal 
postnatal development at birth (A), day 6 (C), day 10 (E) and 
6 months (B) and after exposure to hyperoxia on day 6 (D) 
and 10 (F) at a 200-fold magnification. a = alveolus, br = 
bronchus, bv = blood vessel, s = saccule, tb = terminal bron-
chus.
bv
br
a
a
bv
br
a
a
C D
E
a
a
bv
br
br br
s
A
bv
B
bv a
F
br
bv
aBMC Pulmonary Medicine 2006, 6:8 http://www.biomedcentral.com/1471-2466/6/8
Page 9 of 11
(page number not for citation purposes)
adult rats [16,17]. Our data confirm the observation by
White and co-workers [21] that hyperoxia increases the
tissue expression of surfactant protein mRNAs in newborn
rats. However, earlier (at premature birth, at least 12
hours ahead of the normal birthing period by caesarean
section, versus 48 hours of age) and longer (up to 10 days
instead of 8 days) exposure to hyperoxia in this study pro-
vides new details on the spatial location of the increase in
cellular expression of SP-A and SP-D. During hyperoxia,
SP-A expression mainly increases in Clara cells, whereas
the location of SP-D expression does not change. The ini-
tial decrease in mRNA expression of the collectins after 3
days of exposure to hyperoxia, compared to room-air
exposed controls, supports the findings in adult rats, in
which a temporary decrease in expression of SP-A, -B and
-C was observed after 12 hours of exposure to 95% oxygen
[30]. The cellular expression patterns of SP-A and SP-D
mRNA during neonatal development and after exposure
to hyperoxia were confirmed at the protein level, suggest-
ing regulation of gene expression at a transcriptional level.
High mRNA expression of CC10 in Clara cells was also
confirmed at the protein level, but the relatively low stain-
ing of its mRNA in alveolar type 2 cells could not be estab-
lished at the protein level, suggesting that our
immunohistochemical staining procedure of CC10 is
below the detection level in these cells.
The remarkable upregulation of SP-A and SP-D in preterm
rats exposed to hyperoxia matches the findings in venti-
lated preterm baboons [31] and lambs [32]. In baboons
of 140 days of gestation and ventilated with 100% oxygen
for 10 days, the tissue concentration of SP-A was five and
of SP-D sixteen times greater than in normal adults, but
this was not associated with an increased total collectin
pool in the lavage, suggesting regulation at the transla-
tional level and inhibition of secretion [31]. In preterm
lambs, postnatal changes in surfactant protein gene
expression as a result of hyperoxia are dependent on ges-
tational age [32]. Exposure to hyperoxia had no effect on
SP-A, B, and C mRNA levels in lambs at 120 days of gesta-
tion, but increased SP-A and B mRNA, but not SP-C
mRNA, levels in more mature preterm lambs [32], not
unlike the findings in this study.
Although, the collectins SP-A and -D show a similar gene
expression profile in whole lungs during normal neonatal
development and exposure to hyperoxia, the cellular
expression pattern of both collectins is almost comple-
mentary during the first 10 days after birth: SP-A is present
at high levels in alveolar type 2 cells and in epithelial cells
of terminal bronchi, whereas SP-D is expressed at high
levels in bronchial epithelial Clara cells and at low levels
in alveolar type 2 cells. The increased expression of SP-A
during prolonged hyperoxia was, at least in part, ascribed
to an induction of SP-A mRNA and protein in the bron-
chial epithelium, whereas the expression pattern of SP-D
did not change significantly after prolonged exposure to
100% oxygen. A similar induction of SP-A mRNA expres-
sion in bronchial epithelial cells after exposure to hyper-
oxia has been reported in adult rabbits [19,29] and in
terminal bronchi in newborn rabbits [20], whereas
increased SP-A expression after hyperoxia was attributed
to increased expression in alveolar type 2 cells in newborn
[21] and adult rats [17]. These data strongly indicate that
both alveolar type 2 cells and bronchial Clara cells are
involved in increased synthesis and secretion of SP-A after
oxygen-induced lung injury.
Data on surfactant protein gene expression in preterm
infants ventilated for RDS are not available, although var-
ious studies have measured surfactant protein content in
bronchoalveolar lavage material. Beresford and Shaw [33]
measured surfactant protein concentrations in bronchoal-
veolar lavage by ELISA in a cohort of 50 preterm infants.
SP-A, B, and D concentrations rose significantly during
the first postnatal week and lower broncholaveolar lavage
SP-B and SP-D, but not SP-A, concentrations were associ-
ated with worse clinical prognosis. In a prospective study
Merrill et al. [34] analyzed tracheal aspirate samples from
68 infants of 23–30 weeks of gestation who remained
intubated for 7–84 days. Most preterm infants requiring
continued ventilatory support after 7 days of age experi-
enced a deficiency of SP-B and SP-C. Hallman et al. [35]
reported that infants weighing <1,000 g had a strikingly
lower SP-A/saturated phosphatidylcholine ratio during
the first week of life if they were going to die or develop
bronchopulmonary dysplasia. These studies suggest that
development of bronchopulmonary dysplasia in preterm
infants is associated with reduced concentrations of sur-
factant proteins in bronchoalveolar lavages. This may not
be unlike the situation in ventilated preterm baboons, in
whom upregulation of surfactant protein gene expression
does not increase the surfactant protein pool in the air-
ways due to regulation at the translational level and/or
Table 2: Sequences of oligonucleotides used as forward and reverse primers for PCR
Gene product Forward primer Reverse primer
SP-B 5'-GCCATGGCCAAGTTACATCT-3' 5'-TGCTCACACTTTTGCCTGTC-3'
SP-C 5'-TACTCGACAGGTCCCAGGAG-3' 5'-AGCTCTCCACACAAGGTGCT-3'
CC10 5'-CAACATCAGCCCACATCTACA-3' 5'-TTGGTGTAGGGAGGTCAAGG-3'BMC Pulmonary Medicine 2006, 6:8 http://www.biomedcentral.com/1471-2466/6/8
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inhibition of secretion [31]. We did not measure sur-
factant proteins in lung lavages of the hyperoxia exposed
preterm rats, but would expect their concentrations to fall
in line with the above described reports.
Early hyperoxia exposure in preterm rats rapidly increases
the expression of surfactant proteins in the lung, whereby
SP-A expression is expanded in Clara cells while SP-D
expression does not shift from its initial production sites.
The expanded role of Clara cells in the defence against
hyperoxic injury suggests that they support alveolar type 2
cell function and may play an important role in the supply
of surfactant proteins to the lower airways.
Conclusion
• mRNA levels of all surfactant proteins were high at birth
and increased after prolonged exposure to hyperoxia,
compared to age-matched controls.
• SP-A and SP-C mRNA levels peaked in adult lungs.
• Expression of CC10 mRNA did not change during nor-
mal neonatal lung development and exposure to hyper-
oxia, but peaked in adult lung.
• Similar changes in the cellular expression patterns of
CC10, SP-A and SP-D at the mRNA and protein level dur-
ing normal neonatal development and after exposure to
hyperoxia suggests regulation of gene expression at a tran-
scriptional level.
• The cellular expression pattern of both collectins SP-A
and SP-D is almost complementary during the first 10
days after birth, despite a similar gene expression profile
in whole lungs.
• The increased expression of SP-A under hyperoxia could
be attributed, at least in part, to an induction of expres-
sion in bronchial Clara cells.
• The expanded role of Clara cells in the defense against
hyperoxic injury suggests that they support alveolar type 2
cell function and may play an important role in the supply
of surfactant proteins to the lower airways.
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